285. ファンコニ貧血 Fanconi anemia Clinical trials / Disease details
臨床試験数 : 59 / 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 155
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04522375 (ClinicalTrials.gov) | October 2021 | 3/8/2020 | Phase I/II Study of FP-045 in Patients With Fanconi Anemia | A Phase 1/2 Multicenter, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Activity of FP-045 in Patients With Fanconi Anemia | Fanconi Anemia | Drug: FP-045 | Foresee Pharmaceuticals Co., Ltd. | NULL | Not yet recruiting | 3 Years | 18 Years | All | 56 | Phase 1/Phase 2 | NULL |